Status:
RECRUITING
Blood Sampling of Healthy Volunteers for Immunological Research
Lead Sponsor:
The Netherlands Cancer Institute
Conditions:
Healthy Volunteers
Eligibility:
All Genders
36+ years
Phase:
NA
Brief Summary
This protocol will be used to collect crucial components of the immune system from healthy volunteers for the characterization of immune cells in fresh blood. A pipeline has been set up for comprehens...
Detailed Description
In order to properly compare the immunobiology of healthy volunteers to (advanced) cancer patients, the investigators use age-matched controls with no history of cancer and no potentially interfering ...
Eligibility Criteria
Inclusion
- Age above 35 years
- Written informed consent
- No history of cancer
- No use of systemic immunosuppressive medication (eg. corticosteroids). Local use of corticosteroids (eg. topical or inhalation) is allowed.
Exclusion
- Fever 14 days before blood withdrawal
- Donated blood for the same program within the last 2 years
- Pregnancy
Key Trial Info
Start Date :
February 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 2 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03819829
Start Date
February 5 2019
End Date
December 2 2027
Last Update
March 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NKI-AVL
Amsterdam, Netherlands, 1066CX